It presents with a broad clinical spectrum, ranging from asymptomatic or non-specific symptoms, such as fatigue or lightheadedness, to severe manifestations, including nausea, vomiting, alteration of consciousness, and even coma, which can be life-threatening 3,4
FDA-approved peptides are safe within their approved uses, but many popular peptides lack extensive human studies for prolonged use
These are often the injuries that frustrate patients because they are painful enough to limit activity but not always severe enough to trigger aggressive treatment in the traditional medical system
Use in Special Populations Pediatric Use : The safety and effectiveness of Napa IV for the treatment of acute pain and fever in pediatric patients ages 2 years and older is supported by evidence from adequate and well-controlled studies of Napa IV in adults